English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16817/19260 (87%)
Visitors : 7027922      Online Users : 372
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/31085

    標題: Glutamine in Alleviation of Radiation-Induced Severe Oral Mucositis: A Meta-Analysis
    作者: Leung, Henry W. C.
    Chan, Agnes L. F.
    貢獻者: China Med Univ, An Nan Hosp
    Chia Nan Univ Pharm & Sci, Dept Informat Management
    Chia Nan Univ Pharm, Dept Pharm
    關鍵字: placebo-controlled trial
    locally advanced head
    日期: 2016
    上傳時間: 2018-01-18 11:41:27 (UTC+8)
    出版者: Routledge Journals, Taylor & Francis Ltd
    摘要: The aim of this meta-analysis was to assess the effectiveness of glutamine to treat severe mucositis induced by radiation therapy in patients with head and neck cancer. We undertook electronic searches of PubMed (1990 to January 2015), Embase (1990 to January 2015), and the Cochrane Library (2013, Issue 2) to identify relevant studies. We included randomized controlled trials of glutamine to alleviate oral mucositis (OM) in patients with head and neck cancer who received radiotherapy. Information regarding methods, patients, results, and risk of bias was independently extracted by two authors. Statistical analyses were conducted to calculate the odds ratio and 95% confidence intervals (95%CIs) using fixed-effect models. We identified five clinical studies that included 234 patients with head and neck cancer. All studies were assessed as being at low risk of bias in most items of six domains. In this meta-analysis, glutamine treatment showed a statistically significant benefit with respect to reducing the risk and severity of OM induced by radiotherapy compared to either placebo or no treatment (risk ratio 0.17, 95%CI 0.06-0.47). Overall, glutamine significantly reduces the risk and severity of OM during radiotherapy or chemotherapy. Further prospective and large trials are required to support the findings.
    Appears in Collections:[藥學系(所)] 期刊論文
    [資訊管理系] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback